Previous 10 | Next 10 |
2023-11-13 18:11:41 ET Summary Becton, Dickinson, and Company is a healthcare company with strong fundamentals and a history of dividend growth. The company has shown robust execution of its 2025 strategy, positioning it for sustained growth and innovation in the medical technolog...
2023-11-13 10:12:35 ET Summary Investors were rewarded with 10%+ dividend increases from Snap-on Tools and ADP in the first half of November. Other companies that rewarded investors in the first two weeks of the month were Emerson, which extended its dividend growth streak to 67 y...
2023-11-13 08:56:43 ET Summary Becton, Dickinson and Company (referred hereon as BD) is a global medical device company with a diversified and high-quality portfolio. BD's three main segments, BD Medical, BD Life Sciences, and BD Interventional, contribute to its strong revenue gr...
2023-11-11 19:40:55 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-11-09 12:39:05 ET Becton, Dickinson and Company (BDX) Q43 2023 Earnings Conference Call November 09, 2023, 08:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom Polen – Chairman, President and ...
2023-11-09 09:42:49 ET More on Becton, Dickinson Becton, Dickinson Stock Is A Hold, Here's Why Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers Becton, Dickinson hikes dividend by 4% to $0.95 Becton, Dickinson Non-GAAP EPS of ...
2023-11-09 06:34:14 ET More on Becton, Dickinson Becton, Dickinson Stock Is A Hold, Here's Why Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers Becton, Dickinson Non-GAAP EPS of $3.42, revenue of $5.1B Becton, Dickinson Q4 202...
2023-11-09 06:32:19 ET More on Becton, Dickinson Becton, Dickinson Stock Is A Hold, Here's Why Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers Becton, Dickinson Q4 2023 Earnings Preview U.S. govt. to restart program to ship f...
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results PR Newswire Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4 revenue from ba...
BD Board Increases Dividend for 52nd Consecutive Year PR Newswire FRANKLIN LAKES, N.J. , Nov. 9, 2023 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.95 per common share, an...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 PR Newswire FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1...